European Journal of Drug Metabolism and Pharmacokinetics

Aims & Scope

Announcement European Journal of Drug Metabolism and Pharmacokinetics invites submission of Original Research, Practical Application, Current Opinion and Review Articles on the topics of preclinical and clinical pharmacokinetics and pharmacodynamics. Submit Now! European Journal of Drug Metabolism and Pharmacokinetics promotes drug development by providing researchers essential information on preclinical and clinical pharmacokinetics & pharmacodynamics, including drug disposition, metabolism, transport and interactions, therapeutic drug monitoring, pharmacokinetic/pharmacodynamic relationship, bioavailability and biopharmacy. As a hybrid journal, European Journal of Drug Metabolism and Pharmacokinetics does not charge authors to publish using the traditional subscription-based publishing route, but does offer the option to publish accepted articles open access if authors so wish or if their funders require (more information). European Journal of Drug Metabolism and Pharmacokinetics offers a range of additional features designed to increase the visibility, readership and educational value of the journal’s content (more information). Contact: For more information about the journal, including pre-submission enquiries, please contact Anton van Rensburg at [email protected]

A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.

Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.

Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.

SJR Quartile by Discipline

Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.

Subject Classification